D-1340-2022 Class II Terminated
FDA drug recall D-1340-2022 was initiated by Loud Muscle Science on June 27, 2022 and is designated Class II. Reason for recall: Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims. The recall status is terminated (terminated February 8, 2023). Affected quantity: 1500 10-count tins.
Recall Details
- Product Type
- Drugs
- Report Date
- July 27, 2022
- Initiation Date
- June 27, 2022
- Termination Date
- February 8, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1500 10-count tins
Product Description
Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
Reason for Recall
Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.
Distribution Pattern
The product was distributed nationwide in the USA and Canada.
Code Information
Lot# C07172101, Exp date: 07/2024.